Korea S.E.
18:00:00 2024-05-16 EDT
5-day change
1st Jan Change
5,560
KRW
-0.54%
-2.80%
-8.40%
2021
Pharmicell Co., Ltd. announced that it has received KRW 22 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., Investment Arm
CI
2021
Pharmicell Co., Ltd. announced that it expects to receive KRW 22 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., Investment Arm and other investors
CI
Pharmicell Co., Ltd.(KOSE:A005690) added to KOSPI 200 Index
June 18, 2012 at 12:00 am
Pharmicell Co., Ltd. will be added to the KOSPI 200 Index.
Pharmicell Co., Ltd. announced that it has received KRW 22 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., Investment Arm
21-06-13
CI
Pharmicell Co., Ltd. announced that it expects to receive KRW 22 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., Investment Arm and other investors
21-06-09
CI
Pharmicell Co., Ltd.(KOSE:A005690) dropped from KOSPI 200 Index
14-06-17
CI
Pharmicell Co., Ltd. announced that it has received KRW 8 billion in funding from KDB Capital Corporation, Investment Arm, Neoplux Co, Ltd., and another investor.
14-04-07
CI
People & Technology Inc. announced that it expects to receive KRW 8 billion in funding.
14-04-04
CI
Pharmicell Seeks Partner
13-02-07
CI
Pharmicell Co., Ltd. acquired ID Biochem, Inc from Isu Chemical Co. Ltd., Woo-Baek Choi and other shareholders for KRW 21 billion.
12-11-08
CI
Pharmicell Co., Ltd.(KOSE:A005690) added to KOSPI 200 Index
12-06-18
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Pharmicell Co., Ltd. is a Korea-based company principally engaged in the biopharmaceutical business. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. It also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides womenâs and menâs apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.
More about the company
1st Jan change
Capi.
-8.40% 247M -2.32% 90.45B +3.68% 41.45B -10.90% 33.57B -19.56% 14.73B -9.06% 12.82B -11.34% 11.7B -43.53% 11.44B +3.75% 8.79B -6.32% 8.35B
Biopharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
PHARMICELL CO., LTD. 
